This is the first comprehensive meta-analysis reporting differences in cardiovascular outcomes between T2DM patients treated with subcutaneous vs
Frontiers in Pharmacology, 13, 935823
What this means in practical terms: the clinical weight loss data you may see cited in the media is largely based on FDA-approved injectable or oral tablet formulations
No, Ozempic has not been approved by the FDA for weight loss, though it has been approved to lower blood sugar levels in adults with type 2 diabetes mellitus, in addition to diet and exercise. Further, Ozempic is also approved to reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes mellitus and known heart disease. By contrast, the FDA has approved Wegovy injections to help adults and children over 12 years old lose weight, along with diet and exercise
It is important to note that semaglutide itself does not directly affect thyroid hormone production or cause primary thyroid dysfunction such as hypothyroidism or hyperthyroidism